4978 — ReproCELL Incorporated Share News
0.000.00%
Brief: Reprocell Applies For Manufacturing & Marketing Approval In Japan For Stem Cell Therapy Stemchymal
Table: Reprocell -2025/26 group results
Table: Reprocell - 9-MTH group results
Table: Reprocell - 6-MTH group results
Table: Reprocell -Q1 group results
Table: Reprocell -2024/25 group results
Table: Reprocell -2024/25 group forecast
Table: Reprocell - 9-MTH group results
Table: Reprocell - 6-MTH group results
Table: Reprocell -Q1 group results
Table: Reprocell -2023/24 group results
Table: Reprocell -2023/24 group forecast
Table: Reprocell - 9-MTH group results
Table: Reprocell - 6-MTH group results
Table: Reprocell -Q1 group results
Table: Reprocell -2022/23 group results
Table: Reprocell -2022/23 group forecast
Table: Reprocell - 9-MTH group results
Table: Reprocell - 6-MTH group results